Ovid Therapeutics Inc. (OVID) SEC Filings — 2024
17 SEC filings for Ovid Therapeutics Inc. (OVID) in 2024.
Filings
- Ovid Therapeutics Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Ovid Therapeutics Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Ovid Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Ovid Therapeutics Relocates Principal Executive Offices — 8-K · Sep 11, 2024
- Ovid Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- Ovid Therapeutics Appoints New CEO — 8-K · Aug 2, 2024
- Ovid Therapeutics Files 8-K — 8-K · Jul 1, 2024
- Ovid Therapeutics Appoints New CEO, Dr. Amit Patel — 8-K · Jun 28, 2024
- Ovid Therapeutics Files 8-K — 8-K · Jun 17, 2024
- Ovid Therapeutics Files 8-K on Shareholder Vote — 8-K · Jun 7, 2024
- Ovid Therapeutics Files Q1 2024 Report — 10-Q · May 14, 2024
- Ovid Therapeutics Inc. Files Definitive Proxy Statement — DEF 14A · Apr 24, 2024
- Ovid Therapeutics Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 8, 2024
- Ovid Therapeutics Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Ovid Therapeutics Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Rubric Capital Management LP Holds 5.3M Ovid Therapeutics Shares — SC 13G/A · Feb 12, 2024
- BlackRock Discloses Passive Stake in Ovid Therapeutics — SC 13G · Jan 29, 2024